Surprise email from Conor McKechnie, GE Healthcare proving the aesthetics of science and the value of blogging: A while (!) back you posted an inspiring piece linking to Harvard’s BioVisions inner life of the cell – it was 2006…It got me thinking that we could do something similarly inspiring with actual cellular images entered into… Continue reading Bright cells, big city: Cellular images hit Broadway
Category: innovation
BioBlocks: outsourcing biotech, one block at a time
Friend Dan Erlanson (Co-Editor in Chief of the niche and smart Fragment-based Drug Design blog Practical Fragments) sent me this story on the recession proof business model of a biotech company called BioBlocks and his founder medical chemist Peter Pallai: Approximately one out of 5,000 compounds pass an initial screen, hit the designated biological target,… Continue reading BioBlocks: outsourcing biotech, one block at a time
Golden day for 23andMe: Time’s 2008 Invention of the Year
This is a golden day for 23andMe despite all crisis worries: Mountain View, CA (PRWEB) October 30, 2008 — TIME Magazine announced today that the Personal Genome Service™ from 23andMe, Inc. has been named 2008’s Invention of the Year. 23andMe was chosen as the year’s most significant invention for its exceptional work in making personal… Continue reading Golden day for 23andMe: Time’s 2008 Invention of the Year
Google’s Chrome browser launches & loves tabs & users
Google Chrome Google on Google Chrome – comic book My time with Chrome on the Windows partition of my old MacBook mirrored in Twitter, echoed by FriendFeed:
What change would you make if society tolerated only 1 change at a time?
Nikola Tesla (portrayed by David Bowie) says in The Prestige: “Society tolerates only one change at a time”. If this was true what only change (difference) would you make? The change could be technological, scientific, economical, political, any kind…a change that would make room for all the other changes.
Patent Board science strength of biotech firms in WSJ
The Wall Street Journal Patent Board Biotechnology Scorecard was published this week in which biotech companies & private research firms are grouped by their Patent Board science strength ranking “which is based on the scale, quality, impact, and nearness to core science of a company’s patent-based intellectual property”. What I found interesting at the first… Continue reading Patent Board science strength of biotech firms in WSJ
Sergey Brin goes mobile in 2000 & a Russian lesson
Sergey Brin, Google co-founder is a very interesting man. His story is the number one immigrant success story in the USA today, I dare say. I have 2 Brin videos to show you today: In the first one, Sergey demonstrates mobility in 2000 in 3 ways with his ‘faint accent that is no longer identifiably… Continue reading Sergey Brin goes mobile in 2000 & a Russian lesson
Innovation is still bottom-up in IT, what about biotech?
Just a simple filtering & highlighting & regurgitating for you based on Andy Oram’s post apropos of the opening of a larger Cambridge, Massachusetts Google office : Why open source developers can be more productive, and other tales from a Google open house Along the lines of self-motivated employees, I asked a manager whether most… Continue reading Innovation is still bottom-up in IT, what about biotech?
